Skip to main content
Fig. 3 | BMC Health Services Research

Fig. 3

From: Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis

Fig. 3

Adjusted mean cancer-related healthcare costs, overall and by service type, during the overall observation period. All commercially insured patients included. Adjusted using the Medical Care component of the Consumer Price Index. Note that there are slight differences in the overall mean cost regardless of hematologic malignancy and the sum of the mean costs by service type due to the use of different modelling techniques to fit the data. *Other outpatient visits include interactions not captured by office visits including home healthcare, walk-in health clinic services, and ambulatory surgical centers. HCT, hematopoietic cell transplantation

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us